## **Core Concept**
Clopidogrel is an antiplatelet medication used to reduce the risk of heart disease and stroke. It works by inhibiting platelet activation and aggregation. The mechanism involves the selective inhibition of the P2Y12 receptor, a subtype of purinergic receptor found on the surface of platelets.

## **Why the Correct Answer is Right**
The correct mechanism of action of clopidogrel involves its conversion to an active metabolite, which then irreversibly binds to and inhibits the P2Y12 receptor on platelets. This receptor is crucial for platelet activation and aggregation because it mediates the platelet response to adenosine diphosphate (ADP). By blocking this receptor, clopidogrel effectively reduces platelet aggregation, thereby exerting its antiplatelet effect. This action prevents thrombus formation and is beneficial in patients at risk of myocardial infarction or stroke.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option is incorrect because it does not accurately describe the mechanism of action of clopidogrel.
- **Option B:** This option is incorrect as it does not relate to the known mechanism of clopidogrel.
- **Option D:** This option is incorrect because it also does not accurately describe how clopidogrel works.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that clopidogrel is a prodrug, which means it requires metabolic activation in the liver to become effective. This process involves the cytochrome P450 system, specifically CYP2C19. Variants in the CYP2C19 gene can affect the metabolism of clopidogrel, leading to variability in its antiplatelet effects among individuals.

## **Correct Answer:** C. Irreversible inhibition of P2Y12 receptor.